Roche and Promega set date for PCR court case
This article was originally published in Clinica
Executive Summary
A date has been set early next year for the long-running Roche PCR intellectual property case. The other party in the US court action, Promega, claims that a result in its favour could see the Swiss company lose control of PCR technology and the licence revenue it produces.